Economics at your fingertips  

Occasional Papers

From Office of Health Economics
Contact information at EDIRC.

Bibliographic data for series maintained by Publications Manager ().

Access Statistics for this working paper series.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

001600: International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa
K. Hernandez-Villafuerte, R. Li, A. Towse and K. Chalkidou
001561: Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies?
A. Towse
000332: Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry
K. Hartley and A. Maynard
000322: Price Comparisons of Identical Products in Japan, the United States and Europe
W.d Reekie
000217: Enhancing the Benefits from Biomedical and Health Research Spillovers
Office of Health Economics and Europe Rand
000216: New Drugs to Tackle Antimicrobial Resistance: EU Policy Options
P. Sharma and A. Towse
000191: Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?
M. Garau, A. Towse and P. Danzon
000171: Critical Review of the Quality and Competition Measures and Identification Strategies Used in Health Care Studies
A. Mordoh
000167: The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?
A. Towse, L. Garrison and R. Puig-Peiro
000106: Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
P. Barnsley, A. Towse, S. Karlsberg Schaffer and J. Sussex
000076: The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness
J. Mestre-Ferrandiz, P. Deverka, M. Pistollato and E. Rosenberg
Page updated 2018-04-22
Sorted by numeric handle